The FDA recently removed semaglutide from its drug shortage list, which has not been considered commercially available since ...
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, which in turn could put many ...
More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback